Skip to main content
SpringerLink
Log in

Infections

  • Chapter
Clinical Hepatology

  • 1838 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Alberti A, Clumeck N, Collins S, et al (2005) Short statement of the first European consensus conference on the treatment of chronic hepatitis B and C in HIV-coinfected patients. J Hepatol 42: 615–24

    Article  PubMed  Google Scholar 

  2. Balayan MS, Fedorova OE, Mikhailov MI, et al (1997) Antibody to hepatitis E virus in HIV-infected individuals and AIDS patients. J Viral Hepatol 4: 279–83

    Article  CAS  Google Scholar 

  3. Bessesen M, Ives D, Condreay L, et al (1999) Chronic active hepatitis B exacerbations in human immunodeficiency virus-infected patients following development of resistance to or withdrawal of lamivudine. Clin Infect Dis 28: 1032–5

    Article  CAS  PubMed  Google Scholar 

  4. Benhamou Y, Bochet M, Di Martino V, et al (1999) Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. The multivir group. Hepatology 30: 1054–8

    Article  CAS  Google Scholar 

  5. Benhamou Y, Bochet M, Thibault V, et al (1999) Long-term incidence of hepatitis B virus resistance to lamivudine in human immunodeficiency virus-infected patients. Hepatology 30: 1302–6

    Article  CAS  PubMed  Google Scholar 

  6. Benhamou Y, Fleury H, Trimoulet P, et al (2006) Anti-hepatitis B virus efficacy of tenofovir disoproxil fumarate in HIV-infected patients. Hepatology 43: 548–55

    Article  CAS  PubMed  Google Scholar 

  7. Benhamou Y, Di Martino V, Bochet M, et al (2001) Factors affecting liver fibrosis in human immunodeficiency virus-and hepatitis C virus-coinfected patients: impact of protease inhibitor therapy. Hepatology 34: 283–7

    Article  CAS  PubMed  Google Scholar 

  8. Berzsenyi MD, Bowden DS, Kelly HA, et al (2007) Reduction in hepatitis C-related liver disease associated with GB virus C in human immunodeficiency virus coinfection. Gastroenterology 133: 1821–30

    Article  PubMed  Google Scholar 

  9. Bodsworth N, Donovan B, Nightingale BN (1989) The effect of concurrent human immunodeficiency virus infection on chronic hepatitis B: a study of 150 homosexual men. J Infect Dis 160: 577–82

    CAS  PubMed  Google Scholar 

  10. Bonacini M, Puoti M (2000) Hepatitis C in patients with human immunodeficiency virus infection. Arch Intern Med 160: 3365–73

    Article  CAS  PubMed  Google Scholar 

  11. Bräu N, Salvatore M, Rios-Bedoya CF, et al (2006) Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy. J Hepatol 44: 47–55

    Article  PubMed  Google Scholar 

  12. Cacoub P, Carrat F, Bédossa P, et al (2008) Comparison of non-invasive liver fibrosis biomarkers in HIV/HCV co-infected patients: the fibrovic study – ANRS HC02. J Hepatol 48: 765–73

    Article  PubMed  Google Scholar 

  13. Carrat F, Bani-Sadr F, Pol S, et al (2004) Pegylated inter-feron alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. JAMA 292: 2839–48

    Article  CAS  PubMed  Google Scholar 

  14. Causse X, Payen JL, Izopet J, et al (2000) Does HIV-infection influence the response of chronic hepatitis C to interferon treatment? A French multicenter prospective study. J Hepatol 32: 1003–10

    Article  CAS  PubMed  Google Scholar 

  15. Chung RT, Andersen J, Volberding P, et al (2004) Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N Engl J Med 351: 451–9

    Article  CAS  PubMed  Google Scholar 

  16. Colin JF, Cazals-Hatem D, Loriot MA, et al (1999) Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 29: 1306–10

    Article  CAS  PubMed  Google Scholar 

  17. Costa-Mattioli M, Allavena C, Poirier AS, et al (2002) Prolonged hepatitis A infection in an HIV-1 seropositive patient. J Med Virol 68: 7–11

    Article  PubMed  Google Scholar 

  18. De Kerguenec C, Hillaire S, Molinié V, et al (2001) Hepatic manifestations of hemophagocytic syndrome: a study of 30 cases. Am J Gastroenterol 96: 852–7

    Google Scholar 

  19. Di Martino V, Thevenot T, Colin JF, et al (2002) Influence of HIV infection on the response to interferon therapy and the long-term outcome of chronic hepatitis B. Gastroenterology 123: 1812–22

    Article  PubMed  Google Scholar 

  20. Domagk D, Fegeler W, Conrad B, et al (2006) Biliary tract candidiasis: diagnostic and therapeutic approaches in a case series. Am J Gastroenterol 101: 2530–6

    Article  CAS  PubMed  Google Scholar 

  21. El-Serag HB, Giordano TP, Kramer J, et al (2005) Survival in hepatitis C and HIV coinfection: a cohort study of hospitalized veterans. Clin Gastroenterol Hepatol 3: 175–83

    Article  PubMed  Google Scholar 

  22. Freiberg MS, Cheng DM, Kraemer KL, et al (2007) The association between hepatitis C infection and prevalent cardiovascular disease among HIV-infected individuals. AIDS 21: 193–7

    Article  PubMed  Google Scholar 

  23. Gaslightwala I, Bini EJ (2006) Impact of human immunode-ficiency virus infection on the prevalence and severity of steatosis in patients with chronic hepatitis C virus infection. J Hepatol 44: 1026–32

    Article  CAS  PubMed  Google Scholar 

  24. Graham CS, Curry M, He Q, et al (2004) Comparison of HCV-specific intrahepatic CD4+ T cells in HIV/HCV versus HCV. Hepatology 40: 125–32

    Article  CAS  PubMed  Google Scholar 

  25. Greub G, Ledergerber B, Battegay M, et al (2000) Clinical progression, survival, and immune recovery during antiretro-viral therapy in patients with HIV-1 and hepatitis C virus coin-fection. The Swiss HIV cohort study. Lancet 356: 1800–5

    CAS  Google Scholar 

  26. Hadler SC, Judson FN, O'Malley PM, et al (1991) Outcome of hepatitis B virus infection in homosexual men and its relationship to prior human immunodeficiency virus infection. J Infect Dis 162: 454–9

    Google Scholar 

  27. Harcourt G, Gomperts E, Donfield S, et al (2006) Diminished frequency of hepatitis C virus specific interferon {gamma} secreting CD4+ T cells in human immunodeficiency virus/ hepatitis C virus coinfected patients. Gut. 55: 1484–7

    Article  CAS  PubMed  Google Scholar 

  28. Ida S, Tachikawa N, Nakajima A, et al (2002) Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection. Clin Infect Dis 34: 379–85

    Article  PubMed  Google Scholar 

  29. Kelleher TB, Mehta SH, Bhaskar R, et al (2005) Prediction of hepatic fibrosis in HIV/HCV coinfected patients using serum fibrosis markers: The SHASTA index. J Hepatol 43: 78–84

    Article  PubMed  Google Scholar 

  30. Koziel MJ, Peters MG (2007) Viral hepatitis in HIV infection. N Engl J Med 356: 1445–54

    Article  CAS  PubMed  Google Scholar 

  31. Lafeuillade A, Hittinger G, Chadapaud S (2001) Increased mitochondrial toxicity with ribavirin in HIV/HCV coinfec-tion. Lancet 357: 280–1

    Article  CAS  PubMed  Google Scholar 

  32. Laguno M, Murillas J, Blanco JL, et al (2004) Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for treatment of HIV/HCV coinfected patients. AIDS 18: F27–36

    Article  CAS  PubMed  Google Scholar 

  33. Libman H, Saitz R, Nunes D, et al (2006) Hepatitis C infection is associated with depressive symptoms in HIV-infected adults with alcohol problems. Am J Gastroenterol 101: 1804–10

    Article  PubMed  Google Scholar 

  34. Macias J, Giron-Gonzalez JA, Gonzalez-Serrano M, et al (2006) Prediction of liver fibrosis in human immunodefi-ciency virus/hepatitis C virus coinfected patients by simple non-invasive indexes. Gut 55: 409–14

    Article  CAS  PubMed  Google Scholar 

  35. Merriman NA, Porter SB, Brensinger CM, et al (2006) Racial difference in mortality among U.S. veterans with HCV/HIV coinfection. Am J Gastroenterol 101: 1–8

    Article  Google Scholar 

  36. Moreno A, Barcena R, Garcia-Garzon S, et al (2005) HCV clearance and treatment outcome in genotype 1 HCV-monoinfected, HIV-coinfected and liver transplanted patients on peg-IFN-alpha-2b/ribavirin. J Hepatol 43: 783–90

    Article  CAS  PubMed  Google Scholar 

  37. Ng KP, He J, Saw TL, et al (2000) A seroprevalence study of viral hepatitis E infection in human immunodeficiency virus type 1 infected subjects in Malaysia. Med J Malaysia 55: 58–64

    CAS  PubMed  Google Scholar 

  38. Overton ET, Nurutdinova D, Sungkanuparph S, et al (2007) Predictors of immunity after hepatitis A vaccination in HIV-infected persons. J Viral Hepatol 14: 189–93

    Article  CAS  Google Scholar 

  39. Overton ET, Sungkanuparph S, Powderly WG, et al (2005) Undetectable plasma HIV RNA load predicts success after hepatitis B vaccination in HIV-infected persons. Clin Infect Dis 41: 1045–8

    Article  PubMed  Google Scholar 

  40. Perez-Olmeda M, Nunez M, Romero M, et al (2003) Pegylated IFN-alpha2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients. AIDS 17: 1023–8

    Article  CAS  PubMed  Google Scholar 

  41. Peters MG, Andersen J, Lynch P, et al (2006) Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127. Hepatology 44: 1110–6

    Article  CAS  PubMed  Google Scholar 

  42. Petrovic LM (2007) HIV/HCV coinfection: histopathologic findings, natural history, fibrosis, and impact of antiretrovi-ral treatment: a review article. Liver Int 27: 598–606

    Article  PubMed  Google Scholar 

  43. Pineda JA, Romero-Gomez M, Diaz-Garcia F, et al (2005) HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 41: 779–89

    Article  PubMed  Google Scholar 

  44. Poles MA, Dieterich DT, Schwarz ED, et al (1996) Liver biopsy findings in 501 patients infected with human immu-nodeficiency virus (HIV). J Acquir Immune Defic Syndr Hum Retrovirol 11: 170–7

    CAS  PubMed  Google Scholar 

  45. Poles MA, Dieterich DT (2000) Infections of the liver in HIV-infected patients. Infect Dis Clin North Am 14: 741–59

    Article  CAS  PubMed  Google Scholar 

  46. Puoti M, Rossi S, Forleo MA, et al (1998) Treatment of chronic hepatitis D with interferon alpha-2b in patients with human immunodeficiency virus infection. J Hepatol 29: 45–52

    Article  CAS  PubMed  Google Scholar 

  47. Puoti M, Zanini B, Quinzan GP, et al (2004) A randomized, controlled trial of triple antiviral therapy as initial treatment of chronic hepatitis C in HIV-infected patients. J Hepatol 41: 312–8

    Article  CAS  PubMed  Google Scholar 

  48. Rodriguez-Torres M, Govindarajan S, Solá R, et al (2008) Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study. J Hepatol 48: 756–64

    Article  PubMed  Google Scholar 

  49. Rodriguez-Torres M, Rodriguez-Orengo JF, Rios-Bedoya CF, et al (2007) Effect of hepatitis C virus treatment in fibro-sis progression rate (FPR) and time to cirrhosis (TTC) in patients coinfected with human immunodeficiency virus: A paired liver biopsy study. J Hepatol 46: 613–9

    Article  CAS  PubMed  Google Scholar 

  50. Rutschmann OT, Negro F, Hirschel B, et al (1998) Impact of treatment with human immunodeficiency virus (HIV) protease inhibitors on hepatitis C viremia in patients coinfected with HIV. J Infect Dis 177: 783–5

    Article  CAS  PubMed  Google Scholar 

  51. Salmon-Ceron D, Lewden C, Morlat P, et al (2005) Liver disease as a major cause of death among HIV infected patients: role of hepatitis C and B viruses and alcohol. J Hepatol 42: 799–805

    Article  CAS  PubMed  Google Scholar 

  52. Sauleda S, Juárez A, Esteban JI, et al (2001) Interferon and ribavirin combination therapy for chronic hepatitis C in human immunodeficiency virus-infected patients with congenital coagulation disorders. Hepatology 34: 1035–40

    Article  CAS  PubMed  Google Scholar 

  53. Schiano TD, Kotler DP, Ferran E, et al (2007) Hepatoportal sclerosis as a cause of noncirrhotic portal hypertension in patients with HIV. Am J Gastroenterol 102: 2536–40

    Article  PubMed  Google Scholar 

  54. Sheng WH, Hung CC, Kao JH, et al (2007) Impact of hepatitis D virus infection on the long-term outcomes of patients with hepatitis B virus and HIV coinfection in the era of highly active antiretroviral therapy: a matched cohort study. Clin Infect Dis 44: 988–95

    Article  PubMed  Google Scholar 

  55. Sherman KE, Peters M, Koziel MJ (2007) HIV and liver disease forum: conference proceedings. Hepatology 45: 1566–77

    Article  PubMed  Google Scholar 

  56. Sherman KE, Rouster SD, Chung R, et al (2000) Hepatitis C prevalence in HIV-infected patients: a cross sectional analysis of the US adults AIDS clinical trials group. Antiviral Ther 5(Suppl 1): 64

    Google Scholar 

  57. Sherman KE, Shire NJ, Rouster SD, et al (2005) Viral kinetics in hepatitis C or hepatitis C/human immunodeficiency virus-infected patients. Gastroenterology 128: 313–27

    Article  CAS  PubMed  Google Scholar 

  58. Soriano V, Sheldon J, Garcia-Gasco P, et al (2007) Lack of anti-HIV activity of entecavir in an HIV patient coinfected with hepatitis B and delta viruses. AIDS 21: 2253–4

    Article  PubMed  Google Scholar 

  59. Spada E, Genovese D, Tosti ME, et al (2005) An outbreak of hepatitis A virus infection with high case-fatality rate among injecting drug users. J Hepatol 43: 958–64

    Article  PubMed  Google Scholar 

  60. Sterling RK, Contos MJ, Smith PG, et al (2008) Steatohepatitis: Risk factors and impact on disease severity in human immunodeficiency virus/hepatitis C virus coinfec-tion. Hepatology 47: 1118–27

    Article  CAS  PubMed  Google Scholar 

  61. Sterling RK, Lissen E, Clumeck N, et al (2006) Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection. Hepatology 43: 1317–25

    Article  CAS  PubMed  Google Scholar 

  62. Sulkowski MS, Moore RD, Mehta SH, et al (2002) Hepatitis C and progression of HIV disease. JAMA 288: 199–206

    Article  PubMed  Google Scholar 

  63. Sulkowski MS, Thomas DL (2003) Hepatitis C in the HIV-infected person. Ann Intern Med 138: 197–207

    PubMed  Google Scholar 

  64. Thomas DL (2006) Growing importance of liver disease in HIV-infected persons. Hepatology 43: S221–9

    Article  PubMed  Google Scholar 

  65. Tien PC (2005) Management and treatment of hepatitis C virus infection in HIV-infected adults: recommendations from the Veterans Affairs Hepatitis C Resource Center Program and National Hepatitis C Program Office. Am J Gastroenterol 100: 2338–54

    Article  PubMed  Google Scholar 

  66. Tillmann HL, Heiken H, Knapik-Botor A, et al (2001) Infection with GB virus C and reduced mortality among HIV-infected patients. N Engl J Med 345: 715–24

    Article  CAS  PubMed  Google Scholar 

  67. Torriani FJ, Rodriguez-Torres M, Rockstroh JK, et al (2004) Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N Engl J Med 351: 438–50

    Article  CAS  PubMed  Google Scholar 

  68. Tsui WM, Wong KF, Tse CC (1992) Liver changes in reactive haemophagocytic syndrome. Liver 12: 363–7

    CAS  PubMed  Google Scholar 

  69. Vogel M, Nattermann J, Baumgarten A, et al (2006) Pegylated interferon-alpha for the treatment of sexually transmitted acute hepatitis C in HIV-infected individuals. Antivir Ther 11: 1097–101

    CAS  PubMed  Google Scholar 

  70. Weissman, Feucht C, Moore BA (2006) Response to hepatitis A vaccine in HIV-positive patients. J Viral Hepatol 13: 81–6

    Article  CAS  Google Scholar 

  71. Williams CF, Klinzman D, Yamashita TE, et al (2004) Persistent GB virus C infection and survival in HIV-infected men. N Engl J Med 350: 981–90

    Article  CAS  PubMed  Google Scholar 

  72. Xiang J, Wunschmann S, Diekema DJ, et al (2001) Effect of coinfection with GB virus C on survival among patients with HIV infection. N Engl J Med 345: 707–14

    Article  CAS  PubMed  Google Scholar 

  73. Zylberberg H, Benhamou Y, Lagneaux JL, et al (2000) Safety and efficacy of interferon-ribavirin combination therapy in HCV-HIV coinfected subjects: an early report. Gut 47: 694–7

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Chair, Department of Medicine II, Klinikum Offenbach, Goethe University Frankfurt/Main, Starkenburgring 66, Offenbach, 63069, Germany

    Henryk Dancygier (Professor of Medicine)

  2. Department of Medicine, Division of Liver Diseases, Mount Sinai School of Medicine, New York, NY, USA

    Henryk Dancygier (Professor of Medicine)

Authors
  1. Henryk Dancygier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Dancygier, H. (2010). Infections. In: Clinical Hepatology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-04519-6_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-04519-6_15

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-04509-7

  • Online ISBN: 978-3-642-04519-6

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation